10-Q Filing

Oruka Therapeutics, Inc. CIK: 907654 Q3 2012

Filing Information

Form Type	10-Q
Accession Number	`0001193125-12-467759`
Period End Date	20120930
Filing Date	20121113
Fiscal Year	2012
Fiscal Period	Q3
XBRL Instance	abio-20120930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 57 Income Statement 103 Cash Flow Statement 153 Stockholders Equity 67

Balance Sheet 57 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.18M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	14.62M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.03M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.75M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.08M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.94M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$269.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.18M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	14.62M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$184.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$6.21M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.27M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$33.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$66.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$224.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$164.00K	USD	Point-in-time
Total assets	`Assets`	$6.50M	USD	Point-in-time
Total assets	`Assets`	$3.46M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$260.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$119.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$111.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$80.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherLiabilitiesCurrent`	$350.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherLiabilitiesCurrent`	$63.00K	USD	Point-in-time
Deferred rent, current portion	`DeferredRentCreditCurrent`	$33.00K	USD	Point-in-time
Deferred rent, current portion	`DeferredRentCreditCurrent`	$24.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$754.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$286.00K	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	-	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$16.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$770.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$286.00K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized; 14,619,598 and 12182999 shares issued and outstanding at September 30, 2012 and December 31, 2011, respectively	`CommonStockValue`	$15.00K	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized; 14,619,598 and 12182999 shares issued and outstanding at September 30, 2012 and December 31, 2011, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$70.31M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$69.39M	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-63.67M	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-67.15M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-38.18M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-5.74M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-619.00K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$3.18M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-115.00K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	-	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-19.69M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$7.41M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-678.00K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$6.77M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$5.73M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$6.50M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$3.46M	USD	Point-in-time

Income Statement 103 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$533.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$42.49M	USD	43 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.72M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$156.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$901.00K	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.29M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$4.01M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.58M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$41.94M	USD	43 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$772.00K	USD	1 Quarter
Merger transaction costs	`BusinessCombinationAcquisitionRelatedCosts`	-	USD	3 Qtrs
Merger transaction costs	`BusinessCombinationAcquisitionRelatedCosts`	-	USD	1 Quarter
Merger transaction costs	`BusinessCombinationAcquisitionRelatedCosts`	-	USD	1 Quarter
Merger transaction costs	`BusinessCombinationAcquisitionRelatedCosts`	-	USD	3 Qtrs
Merger transaction costs	`BusinessCombinationAcquisitionRelatedCosts`	$5.47M	USD	43 Qtrs
Restructuring expense, net	`RestructuringCharges`	$2.41M	USD	43 Qtrs
Restructuring expense, net	`RestructuringCharges`	-	USD	1 Quarter
Restructuring expense, net	`RestructuringCharges`	-	USD	3 Qtrs
Restructuring expense, net	`RestructuringCharges`	-	USD	3 Qtrs
Restructuring expense, net	`RestructuringCharges`	-	USD	1 Quarter
Loss on impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Loss on impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Loss on impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$6.00M	USD	43 Qtrs
Loss on impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	3 Qtrs
Loss on impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$3.48M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$928.00K	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$5.73M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$98.30M	USD	43 Qtrs
Total costs and expenses	`OperatingExpenses`	$1.82M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-98.30M	USD	43 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-5.73M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-928.00K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.82M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.48M	USD	3 Qtrs
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	-	USD	3 Qtrs
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$25.28M	USD	43 Qtrs
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	-	USD	1 Quarter
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	-	USD	1 Quarter
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$25.30M	USD	Point-in-time
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	-	USD	3 Qtrs
Gain on assignment of patent rights	`GainLossOnAssignmentOfPatentRights`	-	USD	1 Quarter
Gain on assignment of patent rights	`GainLossOnAssignmentOfPatentRights`	$2.00M	USD	43 Qtrs
Gain on assignment of patent rights	`GainLossOnAssignmentOfPatentRights`	-	USD	1 Quarter
Gain on assignment of patent rights	`GainLossOnAssignmentOfPatentRights`	$2.00M	USD	3 Qtrs
Gain on assignment of patent rights	`GainLossOnAssignmentOfPatentRights`	-	USD	3 Qtrs
Interest and other income	`InterestAndOtherIncome`	$2.00K	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$2.03M	USD	43 Qtrs
Interest and other income	`InterestAndOtherIncome`	$1.00K	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$2.00K	USD	3 Qtrs
Interest and other income	`InterestAndOtherIncome`	$3.00K	USD	3 Qtrs
Interest and other expense	`InterestExpenseDebt`	$9.00K	USD	3 Qtrs
Interest and other expense	`InterestExpenseDebt`	$3.00K	USD	3 Qtrs
Interest and other expense	`InterestExpenseDebt`	$442.00K	USD	43 Qtrs
Interest and other expense	`InterestExpenseDebt`	$1.00K	USD	1 Quarter
Interest and other expense	`InterestExpenseDebt`	$2.00K	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.82M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-69.44M	USD	43 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-927.00K	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.48M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.73M	USD	3 Qtrs
Benefit from income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-2.28M	USD	43 Qtrs
Benefit from income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Benefit from income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Benefit from income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Net Loss and Comprehensive Loss	`NetIncomeLoss`	$-8.42M	USD	Annual
Net Loss and Comprehensive Loss	`NetIncomeLoss`	$-511.00K	USD	Annual
Net Loss and Comprehensive Loss	`NetIncomeLoss`	$-5.24M	USD	Annual
Net Loss and Comprehensive Loss	`NetIncomeLoss`	$-13.99M	USD	Annual
Net Loss and Comprehensive Loss	`NetIncomeLoss`	$-9.14M	USD	Annual
Net Loss and Comprehensive Loss	`NetIncomeLoss`	$-927.00K	USD	1 Quarter
Net Loss and Comprehensive Loss	`NetIncomeLoss`	$-1.46M	USD	Annual
Net Loss and Comprehensive Loss	`NetIncomeLoss`	$-5.36M	USD	Annual
Net Loss and Comprehensive Loss	`NetIncomeLoss`	$-19.43M	USD	Annual
Net Loss and Comprehensive Loss	`NetIncomeLoss`	$-3.73M	USD	3 Qtrs
Net Loss and Comprehensive Loss	`NetIncomeLoss`	$-3.48M	USD	3 Qtrs
Net Loss and Comprehensive Loss	`NetIncomeLoss`	$-116.00K	USD	8 Qtrs
Net Loss and Comprehensive Loss	`NetIncomeLoss`	$-67.15M	USD	43 Qtrs
Net Loss and Comprehensive Loss	`NetIncomeLoss`	$-1.82M	USD	1 Quarter
Less: Accretion of redeemable convertible preferred stock	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	1 Quarter
Less: Accretion of redeemable convertible preferred stock	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	3 Qtrs
Less: Accretion of redeemable convertible preferred stock	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	1 Quarter
Less: Accretion of redeemable convertible preferred stock	`PreferredStockAccretionOfRedemptionDiscount`	$245.00K	USD	43 Qtrs
Less: Accretion of redeemable convertible preferred stock	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	3 Qtrs
Less: Deemed preferred stock dividend for additional common shares issuable under anti-dilution provisions	`PreferredStockDividendsAndOtherAdjustments`	-	USD	1 Quarter
Less: Deemed preferred stock dividend for additional common shares issuable under anti-dilution provisions	`PreferredStockDividendsAndOtherAdjustments`	-	USD	3 Qtrs
Less: Deemed preferred stock dividend for additional common shares issuable under anti-dilution provisions	`PreferredStockDividendsAndOtherAdjustments`	$781.00K	USD	43 Qtrs
Less: Deemed preferred stock dividend for additional common shares issuable under anti-dilution provisions	`PreferredStockDividendsAndOtherAdjustments`	-	USD	3 Qtrs
Less: Deemed preferred stock dividend for additional common shares issuable under anti-dilution provisions	`PreferredStockDividendsAndOtherAdjustments`	-	USD	1 Quarter
Net Loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.82M	USD	1 Quarter
Net Loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-927.00K	USD	1 Quarter
Net Loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.73M	USD	3 Qtrs
Net Loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.48M	USD	3 Qtrs
Net Loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-68.18M	USD	43 Qtrs
Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.17	USD	1 Quarter
Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.38	USD	3 Qtrs
Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.27	USD	3 Qtrs
Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	10.50M	shares	1 Quarter
Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.68M	shares	3 Qtrs
Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.70M	shares	1 Quarter
Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.82M	shares	3 Qtrs

Cash Flow Statement 153 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-8.42M	USD	Annual
Net loss	`NetIncomeLoss`	$-511.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-5.24M	USD	Annual
Net loss	`NetIncomeLoss`	$-13.99M	USD	Annual
Net loss	`NetIncomeLoss`	$-9.14M	USD	Annual
Net loss	`NetIncomeLoss`	$-927.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.46M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.36M	USD	Annual
Net loss	`NetIncomeLoss`	$-19.43M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.73M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.48M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-116.00K	USD	8 Qtrs
Net loss	`NetIncomeLoss`	$-67.15M	USD	43 Qtrs
Net loss	`NetIncomeLoss`	$-1.82M	USD	1 Quarter
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	-	USD	3 Qtrs
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$25.28M	USD	43 Qtrs
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	-	USD	1 Quarter
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	-	USD	1 Quarter
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$25.30M	USD	Point-in-time
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	-	USD	3 Qtrs
Gain on patent rights assignment	`GainLossOnAssignmentOfPatentRights`	-	USD	1 Quarter
Gain on patent rights assignment	`GainLossOnAssignmentOfPatentRights`	$2.00M	USD	43 Qtrs
Gain on patent rights assignment	`GainLossOnAssignmentOfPatentRights`	-	USD	1 Quarter
Gain on patent rights assignment	`GainLossOnAssignmentOfPatentRights`	$2.00M	USD	3 Qtrs
Gain on patent rights assignment	`GainLossOnAssignmentOfPatentRights`	-	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$518.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$34.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.77M	USD	43 Qtrs
Non-cash interest expense	`PaidInKindInterest`	-	USD	3 Qtrs
Non-cash interest expense	`PaidInKindInterest`	-	USD	3 Qtrs
Non-cash interest expense	`PaidInKindInterest`	$211.00K	USD	43 Qtrs
Share-based compensation	`ShareBasedCompensation`	$243.00K	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$232.00K	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$2.52M	USD	43 Qtrs
Issuance of warrants for lease termination	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$377.00K	USD	43 Qtrs
Issuance of warrants for lease termination	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	3 Qtrs
Issuance of warrants for lease termination	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	3 Qtrs
Accretion of liabilities	`AccretionExpense`	-	USD	3 Qtrs
Accretion of liabilities	`AccretionExpense`	$152.00K	USD	43 Qtrs
Accretion of liabilities	`AccretionExpense`	-	USD	3 Qtrs
Impairment of property and equipment	`ImpairmentOfLongLivedAssetsHeldForUse`	-	USD	3 Qtrs
Impairment of property and equipment	`ImpairmentOfLongLivedAssetsHeldForUse`	$125.00K	USD	43 Qtrs
Impairment of property and equipment	`ImpairmentOfLongLivedAssetsHeldForUse`	-	USD	3 Qtrs
Impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$6.00M	USD	43 Qtrs
Impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	3 Qtrs
Impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	3 Qtrs
Write-off of deferred tax liability	`WriteOffOfDeferredTaxLiability`	$-2.28M	USD	43 Qtrs
Write-off of deferred tax liability	`WriteOffOfDeferredTaxLiability`	-	USD	3 Qtrs
Write-off of deferred tax liability	`WriteOffOfDeferredTaxLiability`	-	USD	3 Qtrs
Gain on marketable securities available for sale	`MarketableSecuritiesGainLoss`	$263.00K	USD	43 Qtrs
Gain on marketable securities available for sale	`MarketableSecuritiesGainLoss`	-	USD	3 Qtrs
Gain on marketable securities available for sale	`MarketableSecuritiesGainLoss`	-	USD	3 Qtrs
(Gain) loss from disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-4.00K	USD	3 Qtrs
(Gain) loss from disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	3 Qtrs
(Gain) loss from disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-83.00K	USD	43 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$-267.00K	USD	43 Qtrs
Other, net	`OtherNoncashIncomeExpense`	-	USD	3 Qtrs
Other, net	`OtherNoncashIncomeExpense`	-	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-219.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-2.76M	USD	43 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$56.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-60.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-7.31M	USD	43 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-60.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.07M	USD	43 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-141.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-104.00K	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-384.00K	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-318.00K	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-19.30M	USD	43 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$-24.00K	USD	43 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$25.00K	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$259.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-96.75M	USD	43 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.41M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.72M	USD	3 Qtrs
Cash received from Merger	`CashAcquiredFromAcquisition`	$30.39M	USD	43 Qtrs
Cash received from Merger	`CashAcquiredFromAcquisition`	-	USD	3 Qtrs
Cash received from Merger	`CashAcquiredFromAcquisition`	-	USD	3 Qtrs
Payment of deferred transaction costs	`OtherPaymentsToAcquireBusinesses`	$1.19M	USD	43 Qtrs
Payment of deferred transaction costs	`OtherPaymentsToAcquireBusinesses`	-	USD	3 Qtrs
Payment of deferred transaction costs	`OtherPaymentsToAcquireBusinesses`	-	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.00K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.00K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.88M	USD	43 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$15.37M	USD	43 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$2.00K	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$358.00K	USD	43 Qtrs
Proceeds from assignment of patent rights	`ProceedsFromSaleOfIntangibleAssets`	$2.00M	USD	43 Qtrs
Proceeds from assignment of patent rights	`ProceedsFromSaleOfIntangibleAssets`	$2.00M	USD	3 Qtrs
Proceeds from assignment of patent rights	`ProceedsFromSaleOfIntangibleAssets`	-	USD	3 Qtrs
Proceeds from assignment of patent rights	`ProceedsFromSaleOfIntangibleAssets`	$2.00M	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.00M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.00K	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$45.05M	USD	43 Qtrs
Proceeds from issuance of convertible notes payable and related warrants for common stock	`ProceedsFromIssuanceOrSaleOfEquity`	$10.84M	USD	43 Qtrs
Proceeds from issuance of convertible notes payable and related warrants for common stock	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	3 Qtrs
Proceeds from issuance of convertible notes payable and related warrants for common stock	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	3 Qtrs
Proceeds from issuance of bank note payable	`ProceedsFromNotesPayable`	-	USD	3 Qtrs
Proceeds from issuance of bank note payable	`ProceedsFromNotesPayable`	$4.00M	USD	43 Qtrs
Proceeds from issuance of bank note payable	`ProceedsFromNotesPayable`	-	USD	3 Qtrs
Proceeds from stock subject to repurchase	`ProceedsFromIssuanceOfRedeemablePreferredStock`	-	USD	3 Qtrs
Proceeds from stock subject to repurchase	`ProceedsFromIssuanceOfRedeemablePreferredStock`	-	USD	3 Qtrs
Proceeds from stock subject to repurchase	`ProceedsFromIssuanceOfRedeemablePreferredStock`	$38.00K	USD	43 Qtrs
Proceeds from the issuance of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	-	USD	3 Qtrs
Proceeds from the issuance of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	-	USD	3 Qtrs
Proceeds from the issuance of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$32.32M	USD	43 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$3.00M	USD	3 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$953.00K	USD	3 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$13.53M	USD	43 Qtrs
Repayment of principal on bank note payable	`RepaymentsOfNotesPayable`	-	USD	3 Qtrs
Repayment of principal on bank note payable	`RepaymentsOfNotesPayable`	-	USD	3 Qtrs
Repayment of principal on bank note payable	`RepaymentsOfNotesPayable`	$4.00M	USD	43 Qtrs
Repayment of principal on convertible notes payables	`RepaymentsOfConvertibleDebt`	-	USD	3 Qtrs
Repayment of principal on convertible notes payables	`RepaymentsOfConvertibleDebt`	-	USD	3 Qtrs
Repayment of principal on convertible notes payables	`RepaymentsOfConvertibleDebt`	$105.00K	USD	43 Qtrs
Repayment of principal on vendor finance agreement	`RepaymentOfPrincipalOnVendorFinanceAgreement`	$280.00K	USD	43 Qtrs
Repayment of principal on vendor finance agreement	`RepaymentOfPrincipalOnVendorFinanceAgreement`	$134.00K	USD	3 Qtrs
Repayment of principal on vendor finance agreement	`RepaymentOfPrincipalOnVendorFinanceAgreement`	$97.00K	USD	3 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$54.78M	USD	43 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$547.00K	USD	3 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.44M	USD	3 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.86M	USD	3 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$3.08M	USD	43 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.28M	USD	3 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.03M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.75M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.08M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.94M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$7.03M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.75M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.08M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.94M	USD	Point-in-time
Interest paid	`InterestPaid`	$4.00K	USD	3 Qtrs
Interest paid	`InterestPaid`	$3.00K	USD	3 Qtrs
Interest paid	`InterestPaid`	$115.00K	USD	43 Qtrs
Accrued interest on notes payable converted to equity	`AccruedInterestOnNotesPayableConvertedToEquity`	$163.00K	USD	43 Qtrs
Accrued interest on notes payable converted to equity	`AccruedInterestOnNotesPayableConvertedToEquity`	-	USD	3 Qtrs
Accrued interest on notes payable converted to equity	`AccruedInterestOnNotesPayableConvertedToEquity`	-	USD	3 Qtrs
Warrant issued in connection with credit facility	`WarrantIssuedInConnectionWithCreditFacility`	$111.00K	USD	43 Qtrs
Warrant issued in connection with credit facility	`WarrantIssuedInConnectionWithCreditFacility`	-	USD	3 Qtrs
Warrant issued in connection with credit facility	`WarrantIssuedInConnectionWithCreditFacility`	-	USD	3 Qtrs
Accrued deferred transaction costs	`AccruedDeferredTransactionCosts`	$482.00K	USD	43 Qtrs
Accrued deferred transaction costs	`AccruedDeferredTransactionCosts`	-	USD	3 Qtrs
Accrued deferred transaction costs	`AccruedDeferredTransactionCosts`	-	USD	3 Qtrs
Vendor finance agreement	`VendorFinanceAgreement`	-	USD	3 Qtrs
Vendor finance agreement	`VendorFinanceAgreement`	-	USD	43 Qtrs
Vendor finance agreement	`VendorFinanceAgreement`	$50.00K	USD	3 Qtrs

Stockholders Equity 67 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-38.18M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-5.74M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-619.00K	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$3.18M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-115.00K	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	-	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-19.69M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$7.41M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-678.00K	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$6.77M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$5.73M	USD	Point-in-time
Deemed preferred stock dividend for additional common shares issuable under anti-dilution provision	`DividendsPreferredStockStock`	$781.00K	USD	Annual
Estimated fair value of warrants issued in connection with convertible notes payable	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$399.00K	USD	Annual
Preferred Stock, Discount on Shares	`PreferredStockDiscountOnShares`	$17.00K	USD	Point-in-time
Restricted stock release from restriction	`AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction`	$75.00K	USD	Annual
Conversion of warrants for preferred stock	`AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock`	$36.00K	USD	Annual
Merger with Nuvelo, Inc., value	`StockIssuedDuringPeriodValueAcquisitions`	$11.91M	USD	Annual
Issuance of warrants for lease termination	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$377.00K	USD	43 Qtrs
Issuance of warrants for lease termination	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	3 Qtrs
Issuance of warrants for lease termination	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	3 Qtrs
Issuance of common stock for cash, net of offering costs, value	`StockIssuedDuringPeriodValueNewIssues`	$7.18M	USD	Annual
Issuance of common stock for cash, net of offering costs, value	`StockIssuedDuringPeriodValueNewIssues`	$4.02M	USD	Annual
Registration statement costs for subsequent resale registration of shares issued in December 2011 equity offering, Value	`RegistrationStatementCostsForSubsequentResaleRegistrationOfSharesIssuedEquityOffering`	$-681.00K	USD	3 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$545.00K	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$243.00K	USD	3 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$39.00K	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$458.00K	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$308.00K	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$845.00K	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$50.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$7.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$54.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$139.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$114.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.00K	USD	8 Qtrs
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$16.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	-	USD	Annual
Issuance of common stock under employee stock purchase plan and upon vesting of restricted stock units, value	`StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan`	$2.00K	USD	Annual
Estimated fair value of warrants issued in connection with lease termination	`AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued`	$377.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-8.42M	USD	Annual
Net loss	`NetIncomeLoss`	$-511.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-5.24M	USD	Annual
Net loss	`NetIncomeLoss`	$-13.99M	USD	Annual
Net loss	`NetIncomeLoss`	$-9.14M	USD	Annual
Net loss	`NetIncomeLoss`	$-927.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.46M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.36M	USD	Annual
Net loss	`NetIncomeLoss`	$-19.43M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.73M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.48M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-116.00K	USD	8 Qtrs
Net loss	`NetIncomeLoss`	$-67.15M	USD	43 Qtrs
Net loss	`NetIncomeLoss`	$-1.82M	USD	1 Quarter
Ending Balance, value	`StockholdersEquity`	$-38.18M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-5.74M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-619.00K	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$3.18M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-115.00K	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	-	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-19.69M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$7.41M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-678.00K	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$6.77M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$5.73M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.